van Os S - Search Results

1

Application of physiologically based absorption and pharmacokinetic modeling in the development process of oral modified release generic products.

Subhani S, Kim C, Muniz P, Rodriguez M, van Os S, Suarez E, Cristofoletti R, Schmidt S, Vozmediano V. Subhani S, et al. Among authors: van os s. Eur J Pharm Biopharm. 2022 Jul;176:87-94. doi: 10.1016/j.ejpb.2022.05.007. Epub 2022 May 19. Eur J Pharm Biopharm. 2022. PMID: 35598768 Review.

2

Lack of bioequivalence between generic risperidone oral solution and originator risperidone tablets.

van Os S, Relleke M, Piniella PM. van Os S, et al. Int J Clin Pharmacol Ther. 2007 May;45(5):293-9. doi: 10.5414/cpp45293. Int J Clin Pharmacol Ther. 2007. PMID: 17542352 Clinical Trial.

3

A phase I dose-escalation and bioequivalence study of a trastuzumab biosimilar in healthy male volunteers.

Wisman LA, De Cock EP, Reijers JA, Kamerling IM, Van Os SH, de Kam ML, Burggraaf J, Voortman G. Wisman LA, et al. Clin Drug Investig. 2014 Dec;34(12):887-94. doi: 10.1007/s40261-014-0247-5. Clin Drug Investig. 2014. PMID: 25377592 Clinical Trial.

4

Pharmacokinetics and pharmacogenetics of capecitabine and its metabolites following replicate administration of two 500 mg tablet formulations.

Queckenberg C, Erlinghagen V, Baken BC, Van Os SH, Wargenau M, Kubeš V, Peroutka R, Novotný V, Fuhr U. Queckenberg C, et al. Among authors: van os sh. Cancer Chemother Pharmacol. 2015 Nov;76(5):1081-91. doi: 10.1007/s00280-015-2840-6. Epub 2015 Aug 5. Cancer Chemother Pharmacol. 2015. PMID: 26242222 Clinical Trial.

5

Dopamine D2R Agonist-Induced Cardiovascular Effects in Healthy Male Subjects: Potential Implications in Clinical Settings.

Abou Farha K, Baljé-Volkers C, Tamminga W, den Daas I, van Os S. Abou Farha K, et al. Among authors: van os s. ISRN Neurol. 2014 Jan 22;2014:956353. doi: 10.1155/2014/956353. eCollection 2014. ISRN Neurol. 2014. PMID: 24587918 Free PMC article.

6

Probenecid interferes with renal oxidative metabolism: a potential pitfall in its use as an inhibitor of drug transport.

Masereeuw R, van Pelt AP, van Os SH, Willems PH, Smits P, Russel FG. Masereeuw R, et al. Among authors: van os sh, van pelt ap. Br J Pharmacol. 2000 Sep;131(1):57-62. doi: 10.1038/sj.bjp.0703541. Br J Pharmacol. 2000. PMID: 10960069 Free PMC article.

7

Cortical excitatory amino acid release and cell function during hypotension in near-term born lambs.

van Os S, Ruitenbeek W, Hopman J, Klaessens J, van de Bor M. van Os S, et al. Among authors: van de bor m. Biol Neonate. 2006;90(2):128-34. doi: 10.1159/000092450. Epub 2006 Mar 30. Biol Neonate. 2006. PMID: 16582537

8

Cerebral oxygen supply during hypotension in near-term lambs: a near-infrared spectroscopy study.

Van Os S, Klaessens J, Hopman J, Liem D, Van De Bor M. Van Os S, et al. Among authors: van de bor m. Brain Dev. 2006 Mar;28(2):115-21. doi: 10.1016/j.braindev.2005.06.002. Epub 2005 Dec 20. Brain Dev. 2006. PMID: 16368208

9

Preservation of electrocortical brain activity during hypoxemia in preterm lambs.

Van Os S, Klaessens J, Hopman J, Liem D, Van de Bor M. Van Os S, et al. Among authors: van de bor m. Exp Brain Res. 2003 Jul;151(1):54-9. doi: 10.1007/s00221-003-1469-6. Epub 2003 May 9. Exp Brain Res. 2003. PMID: 12739090

10

Cerebral O2 supply thresholds for the preservation of electrocortical brain activity during hypotension in near-term-born lambs.

van Os S, Liem D, Hopman J, Klaessens J, van de Bor M. van Os S, et al. Among authors: van de bor m. Pediatr Res. 2005 Mar;57(3):358-62. doi: 10.1203/01.PDR.0000153673.00627.F4. Epub 2005 Jan 19. Pediatr Res. 2005. PMID: 15659700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page